2012 Archived Press Releases

05.16.2012
Syndax Pharmaceuticals Appoints Luke Evnin, Ph.D. to Board of Directors

04.30.2012
Syndax Pharmaceuticals Announces Publication of Entinostat Phase 2 Clinical Trial Data in Journal of Clinical Oncology

04.18.2012
Syndax Pharmaceuticals Appoints Arlene Morris as CEO

04.09.2012
Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer

04.05.2012
Syndax Pharmaceuticals Appoints Arthur M. Pappas to Board of Directors

03.29.2012
Syndax Pharmaceuticals to Present at Upcoming Conferences

02.09.2012
Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models

02.07.2012
Syndax Pharmaceuticals to Present at Upcoming Conferences

01.20.2012
Syndax Founder Ronald M. Evans Wins 2012 Wolf Prize in Medicine

01.05.2012
Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat

Current Press Releases

2011 Archived Press Releases

2010 Archived Press Releases

Older Archived Press Releases

For media inquiries please email info@syndax.com.